Previous studies have reported that Sirt3-deficient mice show accelerated steatosis compared to WT mice because of hyperacetylation and the subsequent reduced activity of mitochondrial metabolic enzymes such as long-chain acyl-CoA dehydrogenase (LCAD) [6]. The gene discussed is ACADL; the disease is steatosis.